Close

Professor Pontiano Kaleebu

Professor of Immunovirology

United Kingdom

Affiliations

MRC/UVRI and LSHTM Uganda Research Unit

Selected Publications

Sudan virus disease in humans.
Whitworth, HS; Meller, M; Zaric, M; Quintard, G; KALEEBU, P; Kirenga, B; Marini, A; Fast, P; Gurrion, S; Malkevich, N; Heinrichs, J; Gupta, SB; Francis, SC;
2026
The Lancet. Global health
Saliva versus lesion swabs for PCR diagnosis of acute-phase clade Ib mpox in Uganda: a prospective matched hospital cohort study.
SERWANGA, J; Kaweesa, RE; Mukisa, D; Odoch, G; Nairuba, B; Ankunda, V; Kiyonga, E; Kato, L; Nambi, RP; Tumusiime, RA; Opio, S; Katende, JS; Sembera, J; Ntabadde, AD; Nsubuga, JB; Ejou, P; Avumegah, MS; Nsereko, C; KALEEBU, P;
2026
The Lancet. Microbe
Ebola outbreak caused by Bundibugyo virus: challenges and priorities for epidemic preparedness and response.
Nachega, JB; Mbala-Kingebeni, P; Mulangu, S; Ndembi, N; Preiser, W; Skinner, D; Sam-Agudu, NA; Ntoumi, F; Tegally, H; Baxter, C; Oliveira, TD; Bosa, HK; KALEEBU, P; Kallay, O; Uthman, OA; Mills, EJ; Rosenthal, PJ; Zumla, A; Muyembe-Tamfum, J-J;
2026
Lancet (London, England)
Application of 7-1-7 framework in prototypical anthrax outbreak: Identifying missed opportunities for early detection in southwestern Uganda, September 2024
Katumba, H; Migisha, R; Mutesi, C; Ainembabazi, B; Naiga, HN; Namakula, LO; Tumwesigye, A; Rwamatware, BM; Tendo Nansikombi, H; Bulage, L; Kwesiga, B; Bahati, M; Esau, M; Lumu, PJ; Nakanjako, GK; Atim, SA; Acaya, S; Atiku, L; Lutwama, JJ; KALEEBU, P; Nakiire, L; Byonanebye, DM; Kakooza, F; Ario, AR;
2026
IJID One Health
A Comparison of F/TAF and F/TDF as HIV Pre-Exposure Prophylaxis in a Predominantly Cisgender Women Population in East and South Africa: A Randomized, Factorial, Noninferiority Trial.
McCormack, S; Dunn, D; KUSEMERERWA, S; Munseri, P; Singh, N; William, W; Mutonyi, G; Bern, H; Goldwirt, L; Kingsley, C; Kroidl, A; HANSEN, CH; Ding, S; KAWUMA, R; Amondi, M; BAHEMUKA, U; Buma, D; Clutterbuck, D; Gaffoor, Z; Jennings, A; Joachim, A; KAKANDE, A; Kalanzi, B; Kisinda, A; Matsoso, M; ... PrEPVacc Study Group,
2026
J Acquir Immune Defic Syndr
Practical guidelines for producing non-replicating canine adenovirus vectors.
Omara, D; Ndekezi, C; Mugaba, S; Nakyanzi, A; Bukenya, H; Bwogi, J; Natwijuka, F; KAPAATA, A; KATO, F; Byamukama, D; Ayebale, ML; Kateete, DP; SERWANGA, J; Cose, S; Obondo, SJ; KALEEBU, P; BALINDA, SN;
2026
PloS one
Global and regional molecular epidemiology of HIV-1 during 1990-2024: systematic review, global survey, and analysis of prevalence.
Khalid, A; Gettins, L; Scullion, L; Liu, X; Lin Wei, LL; Masai, AN; Guerin, PJ; Allel, K; Hemelaar, J; Global HIV Molecular Epidemiology Collaboration,;
2026
The Lancet. Infectious diseases
Understanding trial designs and acceptability of participation in an HIV vaccine trial with concurrent randomisation to oral pre-exposure prophylaxis in East and Southern Africa: a longitudinal qualitative study.
KAWUMA, R; Nakamanya, S; Tarimo, E; Chimukuche, RS; Ambindwile, J; Pamba, D; KUSEMERERWA, S; Munseri, P; Singh, N; Dubé, K; McCormack, S; RUZAGIRA, E; SEELEY, J; PrEPVacc trial team,;
2026
Trials
Estimating HIV incidence and assessing associated risk factors among adults: Evidence from the 2018-2022 HIV vaccine preparedness cohort in Masaka, Uganda
KUSEMERERWA, S; Kansiime, S; Mutonyi, G; KAKANDE, A; Nabukenya, S; Namirembe, A; Erima, N; Asio, DJ; Atuhura, EM; Ssendagire, S; Onyango, M; Fox, J; McCormack, S; KALEEBU, P; RUZAGIRA, E; PrEPVacc Study Team,;
2026
PloS one
Evolutionary dynamics of HIV-1 recombinants: analysis of contemporary and historical viral populations in East Africa.
BALINDA, SN; KAPAATA, A; KATO, F; Nakyanzi, A; Natwijuka, F; Ndekezi, C; Byamukama, D; Omara, D; Mugaba, S; Obuku, AE; Salazar-Gonzalez, JF; KALEEBU, P;
2026
Virology journal
See more information